What is Mindstate Design Labs?
Founded in 2021 and headquartered in Pittsburgh, Pennsylvania, Mindstate Design Labs is dedicated to the precise design of pharmaceuticals aimed at producing novel altered states of consciousness. These compounds are intended for use as mental health therapeutics, addressing a critical need for innovative treatments in psychiatric care. The company's focus on precision-design suggests a rigorous scientific approach to drug development, aiming to create safe and effective interventions for a range of mental health conditions. The enterprise-level funding indicates a commitment to scaling operations and advancing its research and development pipeline.
How much funding has Mindstate Design Labs raised?
Mindstate Design Labs has raised a total of $11.5M across 1 funding round:
Angel/Seed
$11.5M
Angel/Seed (2022): $11.5M with participation from K50 Ventures, Metaplanet Holdings, Page One Ventures, Negev Capital, Day One Ventures, and Initialized Capital
Key Investors in Mindstate Design Labs
K50 Ventures
K50 Ventures is a pre-seed venture capital firm that partners with founders from the very beginning to build impactful companies. They focus on sectors such as healthcare, financial services, and industrials, investing in innovative solutions that reshape traditional models through technology and personalized approaches.
Negev Capital
Negev Capital is a Psychedelic Medical Intervention Investment Fund focused on investing in early-stage companies developing psychedelic medicines for psychiatric conditions. With a fund size of over $30 million, they target investments in the USA, Canada, EU, and Israel, providing capital ranging from $500K to $2M per deal.
Initialized Capital
Initialized Capital is a venture capital firm dedicated to supporting seed stage founders across various sectors including enterprise SaaS, sustainability, health, hard tech, artificial intelligence, infrastructure, consumer, and crypto. With a portfolio that includes inspiring builders and leaders, they focus on providing the necessary tools and guidance for entrepreneurs from the early stages to long-term success.
What's next for Mindstate Design Labs?
With the recent influx of major strategic investment, Mindstate Design Labs is poised for accelerated growth and development. The company is likely to channel these resources into expanding its research capabilities, advancing its drug candidates through clinical trials, and potentially scaling its manufacturing processes. The 'major enterprise-level funding' context suggests that the company is moving beyond early-stage development and is preparing for significant market penetration. Future strategic partnerships and further capital raises may be anticipated as Mindstate Design Labs works towards bringing its novel consciousness-altering pharmaceuticals to market for therapeutic applications.
See full Mindstate Design Labs company page
